NYSE:LH - Laboratory Co. of America Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $305.22
  • Forecasted Upside: 22.51 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$249.15
▼ -0.35 (-0.14%)

This chart shows the closing price for LH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Laboratory Co. of America Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LH

Analyst Price Target is $305.22
▲ +22.51% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Laboratory Co. of America in the last 3 months. The average price target is $305.22, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 22.51% upside from the last price of $249.15.

This chart shows the closing price for LH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Laboratory Co. of America. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/26/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/24/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/25/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/25/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/4/2022MizuhoLower Price Target$354.00 ➝ $323.00Low
5/3/2022Deutsche Bank AktiengesellschaftLower Price Target$294.00 ➝ $265.00Low
5/2/2022Credit Suisse GroupLower Price Target$344.00 ➝ $312.00Medium
4/29/2022Truist FinancialLower Price Target$350.00 ➝ $320.00Low
4/25/2022Wells Fargo & CompanyLower Price TargetEqual Weight$290.00 ➝ $235.00Medium
2/14/2022Morgan StanleyLower Price TargetOverweight$380.00 ➝ $360.00Low
2/11/2022Wells Fargo & CompanyLower Price Target$340.00 ➝ $320.00High
2/11/2022Credit Suisse GroupBoost Price TargetOutperform$340.00 ➝ $344.00High
2/11/2022CitigroupBoost Price Target$340.00 ➝ $350.00High
1/28/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$330.00 ➝ $294.00High
12/20/2021MizuhoBoost Price TargetBuy$332.00 ➝ $354.00Low
12/17/2021Morgan StanleyBoost Price TargetOverweight$377.00 ➝ $380.00Low
12/14/2021Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$330.00 ➝ $340.00Medium
11/1/2021Credit Suisse GroupBoost Price TargetOutperform$336.00 ➝ $338.00Low
10/29/2021Morgan StanleyBoost Price TargetOverweight$368.00 ➝ $377.00Low
8/31/2021Morgan StanleyBoost Price TargetOverweight$273.00 ➝ $368.00Low
8/20/2021Credit Suisse GroupBoost Price TargetOutperform$295.00 ➝ $336.00Low
8/19/2021MizuhoBoost Price TargetBuy$318.00 ➝ $332.00Medium
7/30/2021Truist FinancialBoost Price TargetPositive ➝ Buy$330.00 ➝ $350.00Low
7/30/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$297.00 ➝ $330.00Medium
7/30/2021MizuhoBoost Price TargetBuy$310.00 ➝ $318.00Medium
7/21/2021Robert W. BairdSet Price TargetBuy$276.78Low
5/20/2021ArgusBoost Price TargetAverage ➝ Buy$270.00 ➝ $295.00Medium
5/12/2021MizuhoBoost Price TargetBuy$267.00 ➝ $310.00Low
5/3/2021Truist FinancialBoost Price Target$300.00 ➝ $320.00Low
5/3/2021CitigroupBoost Price Target$278.00 ➝ $312.00Low
5/3/2021Jefferies Financial GroupBoost Price TargetBuy$300.00 ➝ $310.00Low
4/14/2021Truist FinancialBoost Price TargetAbove Average ➝ Buy$280.00 ➝ $300.00Medium
4/1/2021Jefferies Financial GroupReiterated RatingBuyHigh
2/12/2021CitigroupBoost Price TargetBuy$257.00 ➝ $278.00Low
2/12/2021JPMorgan Chase & Co.Boost Price TargetOverweight$261.00 ➝ $279.00Low
2/12/2021MizuhoBoost Price TargetBuy$242.00 ➝ $267.00Low
1/29/2021CitigroupBoost Price TargetBuy$249.00 ➝ $257.00Low
1/14/2021MizuhoBoost Price TargetBuy$234.00 ➝ $242.00Low
1/11/2021ArgusUpgradeHold ➝ Buy$245.00Medium
1/8/2021Wolfe ResearchDowngradeOutperform ➝ Peer PerformHigh
10/28/2020Wells Fargo & CompanyBoost Price TargetOverweight$225.00 ➝ $260.00Low
10/28/2020MizuhoBoost Price TargetBuy$215.00 ➝ $234.00Low
10/27/2020William BlairReiterated RatingOutperformLow
10/14/2020Jefferies Financial GroupBoost Price TargetBuy$183.00 ➝ $230.00Low
7/31/2020MizuhoBoost Price TargetBuy$186.00 ➝ $215.00Low
7/29/2020Bank of AmericaBoost Price TargetBuy$220.00 ➝ $240.00Medium
7/29/2020SunTrust BanksBoost Price TargetPositive ➝ Buy$220.00 ➝ $240.00Medium
7/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$210.00 ➝ $230.00Medium
7/29/2020CitigroupBoost Price TargetBuy$214.00 ➝ $249.00Medium
7/14/2020Bank of AmericaUpgradeNeutral ➝ Buy$194.00 ➝ $220.00High
7/13/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$202.00 ➝ $217.00High
6/10/2020Wells Fargo & CompanyReiterated RatingBuyMedium
6/8/2020Robert W. BairdBoost Price TargetOutperform$199.00 ➝ $219.00Medium
6/4/2020JPMorgan Chase & Co.Boost Price TargetOverweight$118.00 ➝ $223.00Medium
6/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$210.00Medium
5/21/2020SunTrust BanksBoost Price TargetBuy$200.00 ➝ $220.00Medium
5/20/2020Morgan StanleyBoost Price TargetOverweight$241.00 ➝ $244.00Low
5/15/2020MizuhoUpgradeNeutral ➝ Buy$158.00 ➝ $186.00Low
5/5/2020UBS GroupBoost Price TargetBuy$209.00 ➝ $218.00Low
4/30/2020JPMorgan Chase & Co.Boost Price Target$149.00 ➝ $188.00Medium
4/30/2020Morgan StanleyBoost Price TargetOverweight$172.00 ➝ $241.00Medium
4/30/2020Bank of AmericaBoost Price TargetNeutral$147.00 ➝ $190.00Medium
4/29/2020KeyCorpDowngradeOverweight ➝ Sector WeightMedium
4/27/2020Wolfe ResearchUpgradeUnderperform ➝ Market Perform$188.00Medium
4/27/2020CitigroupUpgradeNeutral ➝ Buy$204.00 ➝ $214.00High
4/23/2020BarclaysBoost Price TargetOverweight$188.00 ➝ $195.00Medium
4/16/2020MizuhoLower Price TargetNeutral$163.00 ➝ $158.00Medium
4/13/2020SunTrust BanksLower Price TargetBuy$225.00 ➝ $200.00Medium
4/8/2020Morgan StanleyLower Price TargetOverweight$211.00 ➝ $172.00High
4/2/2020JPMorgan Chase & Co.Lower Price TargetOverweight$182.00 ➝ $149.00Medium
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$215.00 ➝ $170.00Medium
3/30/2020KeyCorpLower Price TargetOverweight$212.00 ➝ $170.00High
3/26/2020BarclaysLower Price TargetOverweight$212.00 ➝ $188.00Low
3/24/2020JPMorgan Chase & Co.Lower Price TargetOverweight$204.00 ➝ $182.00High
2/25/2020MizuhoBoost Price TargetNeutral$174.00 ➝ $190.00High
2/18/2020Morgan StanleyBoost Price TargetOverweight$199.00 ➝ $211.00Medium
2/14/2020Evercore ISIInitiated CoverageBuy$215.00Medium
2/14/2020CitigroupBoost Price TargetNeutral$179.00 ➝ $204.00Low
2/13/2020Piper SandlerBoost Price Target$177.00 ➝ $219.00Low
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$210.00High
1/3/2020Bank of AmericaDowngradeNeutral ➝ UnderperformLow
10/21/2019UBS GroupLower Price TargetBuy$204.00 ➝ $200.00Low
8/23/2019Morgan StanleyBoost Price TargetOverweight$190.00 ➝ $201.00Medium
8/8/2019KeyCorpBoost Price TargetOverweight$172.00 ➝ $192.00Medium
7/26/2019Morgan StanleyBoost Price TargetOverweight$175.00 ➝ $190.00High
7/16/2019Bank of AmericaUpgradeUnderperform ➝ Neutral$174.60Low
7/15/2019BarclaysSet Price TargetBuy$200.00Low
6/20/2019Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$180.00 ➝ $220.00High
5/20/2019MizuhoBoost Price TargetNeutral$150.00 ➝ $174.00Low
5/1/2019CitigroupBoost Price TargetNeutral ➝ Neutral$157.00 ➝ $176.00Low
5/1/2019UBS GroupBoost Price TargetBuy ➝ Buy$178.00 ➝ $195.00Low
4/2/2019Wolfe ResearchInitiated CoverageUnderperformLow
4/2/2019Jefferies Financial GroupUpgradeHold ➝ Buy$154.00 ➝ $190.00Medium
3/18/2019BarclaysBoost Price TargetOverweight ➝ Overweight$165.00 ➝ $173.00Low
2/27/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$160.00 ➝ $164.00Low
2/22/2019Morgan StanleySet Price TargetBuy$175.00Low
2/8/2019UBS GroupSet Price TargetBuy$178.00Low
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$169.00High
1/3/2019Bank of AmericaDowngradeNeutral ➝ UnderperformMedium
12/20/2018Morgan StanleySet Price TargetBuy$177.00Medium
12/9/2018The Goldman Sachs GroupLower Price Target$190.00 ➝ $180.00Low
12/9/2018Morgan StanleyLower Price Target$202.00 ➝ $180.00Low
12/6/2018KeyCorpLower Price TargetOverweight ➝ Overweight$210.00 ➝ $165.00Low
12/3/2018SunTrust BanksLower Price TargetBuy$175.00Low
12/3/2018BarclaysLower Price TargetOverweight ➝ Overweight$205.00 ➝ $165.00Medium
12/3/2018CitigroupLower Price TargetNeutral ➝ Neutral$171.00 ➝ $160.00Medium
12/3/2018William BlairReiterated RatingBuyMedium
12/3/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$202.00 ➝ $180.00Medium
12/3/2018Bank of AmericaDowngradeBuy ➝ NeutralMedium
12/3/2018Craig HallumDowngradeBuy ➝ HoldMedium
12/2/2018The Goldman Sachs GroupLower Price Target$190.00Medium
11/30/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$190.00 ➝ $180.00High
10/30/2018ArgusDowngradeBuy ➝ HoldLow
10/25/2018Robert W. BairdLower Price TargetOutperform$205.00 ➝ $190.00Low
10/25/2018CitigroupLower Price TargetNeutral$184.00 ➝ $171.00Low
10/25/2018MizuhoSet Price TargetHold$169.00Low
10/24/2018William BlairReiterated RatingOutperformMedium
10/19/2018Bank of AmericaInitiated CoverageBuy ➝ BuyLow
10/3/2018Craig HallumLower Price TargetBuy$201.00 ➝ $193.00Low
9/19/2018MizuhoReiterated RatingNeutralLow
9/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$192.00 ➝ $202.00Low
9/4/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$197.00 ➝ $195.00Medium
8/22/2018ArgusReiterated RatingBuyLow
8/20/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$195.00 ➝ $190.00Medium
7/26/2018MizuhoReiterated RatingHold$189.00Low
7/26/2018Jefferies Financial GroupReiterated RatingHold ➝ Neutral$180.00Low
7/20/2018SunTrust BanksReiterated RatingBuy$220.00Low
6/27/2018Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$172.00Medium
6/7/2018KeyCorpUpgradeSector Weight ➝ Overweight$210.00Low
5/25/2018BarclaysBoost Price TargetEqual Weight ➝ Overweight$210.00 ➝ $220.00High
5/25/2018MizuhoReiterated RatingHoldHigh
5/1/2018Robert W. BairdUpgradeNeutral ➝ Outperform$183.00 ➝ $203.00Low
3/23/2018ArgusInitiated CoverageBuy$202.00High
3/8/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$192.00 ➝ $195.00Low
3/6/2018Jefferies Financial GroupReiterated RatingHold$176.00Medium
3/1/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$190.00 ➝ $192.00Medium
2/28/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$182.00 ➝ $192.00Medium
2/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$195.00 ➝ $210.00Medium
2/9/2018CitigroupBoost Price TargetNeutral ➝ Neutral$161.00 ➝ $184.00Medium
2/8/2018Robert W. BairdSet Price TargetNeutral ➝ Hold$150.00 ➝ $183.00High
2/7/2018Craig HallumReiterated RatingBuy$180.00 ➝ $204.00Low
1/29/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ Buy$128.00 ➝ $205.00Low
1/24/2018MizuhoSet Price TargetHold$178.00Low
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$176.00High
12/13/2017BarclaysReiterated RatingBuy$195.00Low
12/1/2017MizuhoSet Price TargetNeutral ➝ Neutral$160.00 ➝ $165.00Medium
11/24/2017Jefferies Financial GroupSet Price TargetHold$167.00Low
10/27/2017Robert W. BairdReiterated RatingHold$150.00N/A
10/26/2017BarclaysBoost Price TargetOverweight$183.00 ➝ $190.00N/A
10/26/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$170.00 ➝ $172.00N/A
10/26/2017Craig HallumReiterated RatingBuy$175.00 ➝ $180.00N/A
10/20/2017Jefferies Financial GroupReiterated RatingHold$170.00N/A
10/17/2017Robert W. BairdReiterated RatingHold$166.00N/A
10/12/2017SunTrust BanksReiterated RatingBuy$190.00N/A
10/12/2017Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Outperform$175.00N/A
9/26/2017KeyCorpReiterated RatingHoldLow
9/17/2017Robert W. BairdReiterated RatingNeutral ➝ HoldLow
9/13/2017Jefferies Financial GroupReiterated RatingHold$157.00 ➝ $170.00Medium
8/10/2017Morgan StanleyBoost Price TargetOverweight$154.00 ➝ $166.00Low
7/27/2017BarclaysBoost Price TargetOverweight$182.00 ➝ $183.00Low
7/27/2017Craig HallumReiterated RatingBuy$157.00 ➝ $179.00Medium
7/17/2017BarclaysReiterated RatingOverweight$175.00 ➝ $182.00Low
7/13/2017Credit Suisse GroupDowngradeHold$146.00Low
5/28/2017Credit Suisse GroupReiterated RatingBuy$146.00Medium
(Data available from 5/25/2017 forward)

News Sentiment Rating

0.12 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
10/27/2021
  • 15 very positive mentions
  • 33 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
11/26/2021
  • 16 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/26/2021
  • 5 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/25/2022
  • 9 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
2/24/2022
  • 1 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/26/2022
  • 7 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2022
  • 5 very positive mentions
  • 15 positive mentions
  • 7 negative mentions
  • 3 very negative mentions
5/25/2022

Current Sentiment

  • 5 very positive mentions
  • 15 positive mentions
  • 7 negative mentions
  • 3 very negative mentions

Recent Stories by Sentiment

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $249.15
Low: $247.61
High: $252.12

50 Day Range

MA: $260.49
Low: $238.59
High: $277.87

52 Week Range

Now: $249.15
Low: $232.01
High: $317.17

Volume

1,463,973 shs

Average Volume

897,355 shs

Market Capitalization

$23.10 billion

P/E Ratio

11.43

Dividend Yield

1.15%

Beta

1.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Laboratory Co. of America?

The following sell-side analysts have issued stock ratings on Laboratory Co. of America in the last year: Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, Robert W. Baird, StockNews.com, Truist Financial Co., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for LH.

What is the current price target for Laboratory Co. of America?

0 Wall Street analysts have set twelve-month price targets for Laboratory Co. of America in the last year. Their average twelve-month price target is $305.22, suggesting a possible upside of 22.5%.
View the latest price targets for LH.

What is the current consensus analyst rating for Laboratory Co. of America?

Laboratory Co. of America currently has 2 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LH will outperform the market and that investors should add to their positions of Laboratory Co. of America.
View the latest ratings for LH.

What other companies compete with Laboratory Co. of America?

How do I contact Laboratory Co. of America's investor relations team?

Laboratory Co. of America's physical mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company's listed phone number is (336) 229-1127 and its investor relations email address is [email protected] The official website for Laboratory Co. of America is www.labcorp.com. Learn More about contacing Laboratory Co. of America investor relations.